Oxford Industries appoints Saroj Kumar Choudhury as CFO
Oxford Industries Limited appointed Mr. Saroj Kumar Choudhury as its Chief Financial Officer effective July 17, 2026. The board accepted the resignation of M/s. PAMS & Associates and appointed M/s. Lipika and Associates as statutory auditor. Additionally, the board proposed a 99% reduction in share capital, shifting the registered office to Orissa, and expanding business objectives into healthcare and pharmaceuticals.

*this image is generated using AI for illustrative purposes only.
Oxford Industries Limited appointed Mr. Saroj Kumar Choudhury as its Chief Financial Officer effective July 17, 2026, during its board meeting. The board also approved the resignation of the existing statutory auditor and the appointment of a new firm, alongside a proposal to reduce the share capital by 99% due to accumulated business losses. These decisions are subject to shareholder approval in the ensuing Annual General Meeting.
The board accepted the resignation of M/s. PAMS & Associates, Chartered Accountants, effective June 19, 2026. The resignation was attributed to geographical constraints, as the firm is based in Bhubaneswar while the company operates from Mumbai. Consequently, the board appointed M/s. Lipika and Associates, Chartered Accountants, as the statutory auditor for a term of five years from FY2026-2027 to FY2030-2031, pending member approval.
Mr. Saroj Kumar Choudhury, who is also the Managing Director, was appointed as the Chief Financial Officer. He recently acquired promoter status following an open offer, holding 27,61,576 shares, which constitutes 46.46% of the paid-up capital. The former promoter, Mr. Mazher N Laila, has ceased to be a promoter and is now classified as a public shareholder.
The board proposed shifting the registered office from Maharashtra to Orissa and approved the enlargement of the Main Object Clause of the Memorandum of Association to include healthcare and pharmaceutical businesses. This involves the insertion of new clauses to establish hospitals, nursing homes, and diagnostic centres, and to trade in pharmaceutical products and medical equipment.
| Agenda Item | Details |
|---|---|
| Statutory Auditor Appointment | M/s. Lipika and Associates (FY2026-2027 to FY2030-2031) |
| Statutory Auditor Resignation | M/s. PAMS & Associates (effective June 19, 2026) |
| CFO Appointment | Mr. Saroj Kumar Choudhury (effective July 17, 2026) |
| Reduction of Share Capital | 99% of issued and paid-up capital |
| Shifting of Registered Office | Maharashtra to Orissa |
| Enlargement of Main Object Clause | Healthcare and pharmaceutical sectors |
The meeting was held in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The board also appointed a registered valuer for the valuation report regarding the capital reduction.
Historical Stock Returns for Oxford Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.51% | -4.91% | -45.08% | +1.64% | +694.87% | +694.87% |
How will the proposed 99% share capital reduction impact the company's ability to raise future funding?
What specific strategic advantages does shifting the registered office to Orissa offer for the new healthcare ventures?
Will the consolidation of the MD and CFO roles in one individual raise governance concerns for minority shareholders?


































